References
- Singh N. Infections with human herpesvirus 6, 7, and 8 after hematopoietic stem cell or solid organ transplantation. InBowden R, Ljungman P, Paya C, editors. Transplant infections. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2004. pp 365–374.
- Betts BC, Young JA, Ustun C, et al. Human herpesvirus 6 infection after hematopoietic cell transplantation: is routine surveillance necessary? Biol Blood Marrow Transplant 2011;17:1562–1568.
- Zerr DM, Corey L, Kim HW, et al. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin Infect Dis 2005;40:932–940.
- Zerr DM, Boeckh M, Delaney C, et al. HHV-6 reactivation and associated sequelae after hematopoietic cell transplantation. Biol Blood Marrow Transplant 2012;18:1700–1708.
- Zhang L, Arrington S, Keung YK. Guillain-Barré syndrome after transplantation. Leuk Lymphoma 2008;49:291–297.
- Tomaszewska A, Nasilowska-Adamska B, Dzieciatkowski T, et al. Simultaneous human herpesvirus 6-associated encephalitis and Guillain-Barré syndrome in a patient after matched unrelated donor haematopoietic stem cell transplantation. Arch Med Sci 2010; 6:288–290.
- Ljungman P, De la Camara R, Cordonnier C, et al. Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT. Bone Marrow Transplant 2008;42:227–240.
- Dewhurst S. Human herpesvirus type 6 and human herpesvirus type 7 infections of the central nervous system. Herpes 2004; 11(Suppl. 2):105A–111A.
- Leong HN, Tuke PW, Tedder RS, et al. The prevalence of chromosomally integrated human herpesvirus 6 genomes in the blood of UK blood donors. J Med Virol 2007;79:45–51.